Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)

• Hoofdauteurs: Aleksandrina Ruseva (Auteur), Wojciech Michalak (Auteur), Zhenxiang Zhao (Auteur), Anthony Fabricatore (Auteur), Bríain Ó. Hartaigh (Auteur), Devika Umashanker (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2024-02-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Management guidelines for obesity suggest maintaining a minimum of 5% body weight reduction to help prevent or lower the risk of developing conditions such as hypertension and type 2 diabetes. However, achieving long‐term weight control is difficult with lifestyle modification al...